The nuclear imaging equipment is used to insert, study, or track radioactive substance in the body to help support prognosis and diagnosis. The global nuclear imaging equipment market is projected to reach USD 2.85 Billion by 2021 from USD 2.25 Billion in 2016, growing at a CAGR of 4.8% during the forecast period of 2016 to 2021. Introduction of new and advanced products, investment for the modernization of Diagnostic Imaging centers, development of new radiotracers, and increasing incidence and prevalence of cancer & cardiovascular diseases are the factors driving the overall nuclear imaging equipment market. High accuracy of nuclear imaging and the improving reimbursement scenario for PET scans is expected to provide growth opportunities for players operating in this market.

Objectives of the Study

To define, describe, and forecast the global nuclear imaging equipment market on the basis of process, end user, and region

To provide detailed information regarding major factors influencing growth of the market (drivers, restraints, opportunities, and industry-specific challenges)

To strategically analyze micromarkets with respect to individual growth trends, future prospects, and contributions to the overall market

To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders

To forecast the size of the nuclear imaging equipment market with respect to four main regions, namely, North America, Europe, Asia-Pacific, and the Rest of the World

To strategically profile the key players in the global nuclear imaging equipment market and comprehensively analyze their core competencies

To track and analyze competitive developments such as joint ventures and alliances, mergers and acquisitions, new product/technology development, and research and development activities of the leading players in the global nuclear imaging equipment market

Research Methodology

Top-down and bottom-up approaches were used to validate the size of the global nuclear imaging equipment market and estimate the size of various other dependent submarkets. Various secondary sources such as directories, industry journals, databases such as Hoover�s, Bloomberg Business, Factiva, and Avention, and annual reports of the companies have been used to identify and collect information useful for the study of this market. Primary sources such as experts from both supply and demand sides have been interviewed to obtain and validate information as well as to assess dynamics of this market. The breakdown of profiles of primaries is shown in the figure below:

To know about the assumptions considered for the study, download the pdf brochure

The major players in the global nuclear imaging equipment market are Siemens Healthineers (Germany), Philips Healthcare (Netherlands), and GE Healthcare (U.S.). The other players in the market include Toshiba Medical Systems Corporation (Japan), Neusoft Medical Systems Co., Ltd. (China), Mediso Medical Imaging Systems Ltd. (Hungary), Digirad Corporation (U.S.), CMR Naviscan Corporation (U.S.), SurgicEye GmbH (Germany), and DDD Diagnostics (Denmark).

Target Audience:

Nuclear imaging equipment manufacturers and suppliers

Healthcare service providers

Health insurance players

Medical device companies

Research and consulting firms

Research institutes

Academic centers

Venture capitalists

Scope of the Report

The research report categorizes the global nuclear imaging equipment market into the following segments and subsegments:

Nuclear Imaging Equipment Market, by Product

SPECT Systems Hybrid SPECT Standalone SPECT

Hybrid PET Systems

Planar Scintigraphy

Nuclear Imaging Equipment Market, by Application

Oncology

Cardiology

Neurology

Other Applications (Orthopedics, Urology, Thyroid-related Disorders, and Gastroenterology)

Nuclear Imaging Equipment Market, by End User

Hospitals

Imaging Centers

Academic and Research Centers

Other End Users (Pharmaceutical/Biotechnology Companies and CROs)

Nuclear Imaging Equipment Market, by Region

North America U.S. Canada

Europe Europe-5 (Includes France, Germany, Italy, Spain, and the U.K.) Russia Rest of Europe (RoE)

Asia-Pacific Japan China India Rest of Asia-Pacific (RoAPAC)

Rest of the World (RoW)

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company�s specific needs. The following customization options are available for the report:

Product Analysis

Product matrix, which gives a detailed comparison of the product portfolios of each company

Geographic Analysis

Further breakdown of the Rest of Asia-Pacific nuclear imaging equipment market into South Korea, Australia, New Zealand, and others

Further breakdown of the Latin American nuclear imaging equipment market into Brazil, Argentina, and the Rest of Latin America

Company Information

Detailed analysis and profiling of additional market players (up to 5)

The nuclear imaging equipment market is projected to reach USD 2.85 Billion by 2021 from USD 2.25 Billion in 2016, growing at a CAGR of 4.8% during the forecast period, owing to factors such as introduction of new and advanced products, investment for the modernization of diagnostic imaging centers, development of new radiotracers, and increasing incidence of cancer & cardiovascular diseases are expected to drive the growth of the market.

The global market is segmented on the basis of product, application, end user, and region. On the basis of product, the market is further divided into SPECT systems, Hybrid PET and Planar Scintigraphy. The SPECT systems segment is expected to command the largest share whereas the Hybrid PET systems are expected to grow at the highest CAGR during the forecast period.

On the basis of application, the market has been segmented into oncology, cardiology, neurology and other applications (orthopedics, urology, thyroid-related disorders, and gastroenterology). The oncology segment is expected to command the largest share of the global market by applications. However, cardiac applications hold the majority share in case of SPECT applications and oncology applications hold the largest share in case of PET applications.

On the basis of end user, the nuclear imaging market is segmented into hospitals, imaging centers, academic & research centers, and other end users (pharmaceutical & biotechnology companies and CROs). In 2016, the hospitals segment is expected to account for the largest share and grow at the highest CAGR during the forecast period.

By region, the global market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World. In 2016, North America is estimated to account for the largest share as in the forecast period of the nuclear imaging equipment market, followed by Asia-Pacific and Europe. Asia-Pacific market is expected to grow at the highest CAGR during the forecast period. This can be attributed to aging population and increasing healthcare expenditure in Japan, developing healthcare infrastructure in China, and increasing adoption of nuclear imaging in India among others.

The major players in the global nuclear imaging equipment market are Siemens Healthineers (Germany), Philips Healthcare (Netherlands), and GE Healthcare (U.S.). The other players in the market include Toshiba Medical Systems Corporation (Japan), Neusoft Medical Systems Co., Ltd. (China), Mediso Medical Imaging Systems Ltd. (Hungary), Digirad Corporation (U.S.), CMR Naviscan Corporation (U.S.), SurgicEye GmbH (Germany), and DDD Diagnostics (Denmark).

To speak to our analyst for a discussion on the above findings, click Speak to Analyst